Granisetron hydrochloride and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Granisetron hydrochloride (granisetron hydrochloride) and Neupogen (filgrastim). Common drug interactions include febrile neutropenia among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Granisetron hydrochloride and Neupogen. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Granisetron hydrochloride?

Granisetron hydrochloride has active ingredients of granisetron hydrochloride. eHealthMe is studying from 2,332 Granisetron hydrochloride users. Check the latest studies of Granisetron hydrochloride.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 10, 2026

24 people who take Granisetron hydrochloride and Neupogen together, and have interactions are studied.

Granisetron hydrochloride and Neupogen drug interactions.

What are the common drug interactions of Granisetron Hydrochloride and Neupogen, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Haemoglobin decreased
Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dyspnoea (difficult or laboured respiration)
Blood bilirubin increased
Blood urea increased
Clamminess (moist, sticky, and cold to the touch)
Deafness neurosensory

male:

Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Dehydration (dryness resulting from the removal of water)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting
Alanine aminotransferase increased

What are the common drug interactions of Granisetron Hydrochloride and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Febrile neutropenia (fever with reduced white blood cells)
Back pain
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Hypophagia (reduced food intake)
Lactic acidosis (low ph in body tissues)
Productive cough

40-49:

n/a

50-59:

Haemoglobin decreased
Thrombocytopenia (decrease of platelets in blood)
Alanine aminotransferase increased
Blood bilirubin increased
Blood urea increased
Clamminess (moist, sticky, and cold to the touch)
Diarrhoea
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dyspnoea (difficult or laboured respiration)
Gastric ulcer (stomach ulcer)

60+:

Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting

* Approximation only. Some reports may have incomplete information.

Do you take Granisetron hydrochloride and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously